Aevitas Wealth Management, Inc. Voyager Therapeutics, Inc. Transaction History
Aevitas Wealth Management, Inc.
- $169 Million
- Q4 2022
A detailed history of Aevitas Wealth Management, Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Aevitas Wealth Management, Inc. holds 22,000 shares of VYGR stock, worth $126,280. This represents 0.08% of its overall portfolio holdings.
Number of Shares
22,000
Previous 22,000
-0.0%
Holding current value
$126,280
Previous $130,000
3.08%
% of portfolio
0.08%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding VYGR
# of Institutions
130Shares Held
34.7MCall Options Held
39.7KPut Options Held
34.6K-
Black Rock Inc. New York, NY5.31MShares$30.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$29.8 Million0.5% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$22.5 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$18.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$13.2 Million0.07% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $222M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...